GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 81 filers reported holding GALENA BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $52,000 | -52.3% | 33,200 | -48.6% | 0.00% | -75.0% |
Q2 2015 | $109,000 | +127.1% | 64,600 | +311.5% | 0.02% | +77.8% |
Q2 2014 | $48,000 | -94.5% | 15,700 | -95.5% | 0.01% | -78.0% |
Q1 2014 | $871,000 | +427.9% | 348,500 | +946.5% | 0.04% | +156.2% |
Q4 2013 | $165,000 | – | 33,300 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,446,469 | $13,616,000 | 2.03% |
Harbour Capital Advisors, LLC | 78,450 | $196,000 | 0.19% |
SABBY MANAGEMENT, LLC | 708,089 | $1,770,000 | 0.10% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 174,600 | $437,000 | 0.07% |
Alyeska Investment Group, L.P. | 530,000 | $1,950,000 | 0.05% |
HIGHLAND CAPITAL MANAGEMENT LP | 528,027 | $1,320,000 | 0.05% |
KMS FINANCIAL SERVICES, INC | 118,042 | $295,000 | 0.05% |
Quantitative Investment Management, LLC | 348,500 | $871,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 538,100 | $1,345,000 | 0.04% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $74,000 | 0.04% |